Wockhardt gains on receiving QIDP designation for its new drug WCK 4873 from USFDA

22 May 2015 Evaluate

Wockhardt is currently trading at Rs. 1453.00, up by 45.85 points or 3.26% from its previous closing of Rs. 1407.15 on the BSE.

The scrip opened at Rs. 1450.00 and has touched a high and low of Rs. 1459.50 and Rs. 1435.90 respectively. So far 21,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2000.00 on 08-Apr-2015 and a 52 week low of Rs. 543.10 on 10-Jul-2014.

Last one week high and low of the scrip stood at Rs. 1459.50 and Rs. 1305.90 respectively. The current market cap of the company is Rs. 16,012.00 crore.

The promoters holding in the company stood at 74.48% while Institutions and Non-Institutions held 11.53% and 13.86% respectively.

Wockhardt has received Qualified Infectious Disease Product (QIDP) designation for its new Drug WCK 4873 from USFDA. The US Food and Drug Administration (USFDA) has granted WCK 4873, a product from their New Drug Discovery program, Qualified Infectious Disease Product (QIDP) status.

This is the third product from Wockhardt to receive this coveted status after WCK 771 and WCK 2349 last year and provides a strong boost to its drug development program.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.


Wockhardt Share Price

1341.70 6.00 (0.45%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×